iBio Inc.

News

Recent Releases, Events & Media Assets

News

Latest News

iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference

NEW YORK, June 05, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE MKT:IBIO), a leader in developing plant-based biopharmaceuticals, announced today that Barry Holtz, PhD, President of iBio CMO LLC is scheduled to present the Company’s pharmaceutical development and production platforms during two

Read Press Release

Latest Presentation

Upcoming Event

Dr. Carol Fengali-Bostwick presents at the Scleroderma Foundation – Courtesy of the Scleroderma Foundation, Inc.

Learn More

Additional